Inhibition of the SerpinB3/protease-activated receptor 2 axis reduces liver cancer development and affects lipid metabolism.

Pietro Guerra, G. Villano, C. M. Rejano-Gordillo, C. Gil-Pitarch, M. Ruvoletto, A. Biasiolo, S. Quarta, L. E. Zapata-Pavas, P. Peña-Sanfélix, I. González-Recio, Naroa Goikoetxea‐Usandizaga, Jon Ander Barrenechea-Barrenechea, A. Sanz-Parra, A. Gambella, S. de Siervi, B. Oliviero, Stefania Mantovani, J. Nurcis, Silvia Cagnin, A. Martini, C. Turato, S. Cannito, Maria Guido, M. Parola, M.L. Martínez-Chantar, P. Pontisso

2026.4.22/BRITISH JOURNAL OF CANCER